Related Experiment Video
Updated: Aug 10, 2026
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
[Evidence based medical treatment of heart failure]
A Agustí Escasany1, M Durán Dalmau, J M Arnau De Bolós
1Fundación Institut Català de Farmacologia. Servicios de Farmacología Clínica, Barcelona. ag@icf.uab.es
Insights
This systematic review provides evidence-based recommendations for pharmacologic treatments for heart failure. The findings support treatment strategies across all stages of heart failure to improve patient outcomes.
Area of Science:
- Cardiology
- Pharmacology
- Evidence-based Medicine
Background:
- Heart failure (HF) management requires effective pharmacologic interventions.
- Systematic reviews are crucial for synthesizing evidence on HF treatments.
Purpose of the Study:
- To conduct a systematic review of pharmacologic treatments for chronic and systolic heart failure.
- To develop evidence-based treatment recommendations for heart failure.
Main Methods:
- Searched English-language studies on pharmacologic heart failure treatment.
- Classified evidence by efficacy (mortality, hospitalizations, functional class, ejection fraction, exercise tolerance) and quality.
- Evaluated treatment comparisons, combinations, toxicity, and costs.
Main Results:
- Recommendations stratified by NYHA functional class and evidence quality (A, B, C).
- Mortality reduction was a primary consideration.
- Identified first-line, alternative, and other potential heart failure pharmacologic treatments.
Conclusions:
- Sufficient evidence exists for treatment recommendations across all heart failure stages.
- Pharmacologic treatments significantly impact mortality and hospitalization rates.
- Implementing these recommendations can improve heart failure management and patient outcomes.
Introduction And Objectives:
Recommendations for the treatment of heart failure were carried out by a systematic review of the available evidence of the different pharmacologic treatments.
Material And Methods:
The review focused on the treatment of chronic and systolic heart failure. All the studies published in english about the pharmacologic treatment of heart failure where identified. The evidence of every pharmacologic treatment was classified according to: a) efficacy variables (reduction of mortality and hospitalizations, improvement of functional class, ejection fraction and exercise tolerance), and b) the level of quality of the evidence according to an evaluation scale. The evidence was also reviewed for the comparisons and the combinations of the pharmacologic treatments, as well as for the toxicity and costs of treatments.
Results:
The recommendations were defined according to the NYHA functional class and were classified in the A, B and C categories according to the level of quality of the available evidence. The evidence on mortality was considered the most important. First line drugs, the alternatives and other possible treatments were take into account.
Conclusions:
There is enough evidence based on information about some variables such as reduction of mortality or hospitalizations to carry out treatment recommendations in all stages of heart failure. This point out the interest ant the priority of used them in the evaluation and improvement of the results of heart failure.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:22Heart Failure Drugs: β-Blockers
01:21Rheumatic Heart Disease III: Medical Management
01:30Heart Failure V: Medical Management
01:22Heart Failure VI: Adjunct Therapies
01:30Heart Failure VII: Nursing Interventions